FABP1 and metabolic dysfunction-associated steatotic liver disease: The present study investigated the association between serum Liver-type Fatty Acid Binding Protein (L-FABP) levels and non-invasive diagnostic and prognostic measures, including fibrosis stages and Ultrasonographic diagnosis, in individuals with MASLD.